Drug
Indv 6200
Indv 6200: highest development phase Phase 1, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| INDV-6200 NCT03715634 | Phase 1 | Opioid-use Disorder |
Latest
No recent events.
Follow Indv 6200 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.